← Leaderboards
Jesse Samuel Boehm
Massachusetts Institute Of Technology
$3,331,876
Attributed
$3,611,298
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $800.9K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,611,298 · 2
By mechanism
R01$3,192,165 · 1
R33$419,133 · 1
Top collaborators
- Beth Cimini1 shared
- Samuel J Klempner1 shared
Most similar at Massachusetts Institute Of Technology
Same institution · by research overlap
- James G Fox$41,812,600
- Scott R Manalis$18,853,425
- Michael Hemann$6,314,382
- Michael B Yaffe$28,748,219
- Phillip A Sharp$28,187,962
Others in their field
Other Emerging Leaders on “Morbidity - Disease Rate”
- Stephen F Smagula · University Of Pittsburgh At Pittsburgh$5,369,879
- Karen Yazzie · Fort Belknap Indian Community$2,692,724
- Henning Tiemeier · University Of Chicago$2,503,974
- Molly Adrian · Seattle Children'S Hospital$2,302,897
- Shabbar I Ranapurwala · Univ Of North Carolina Chapel Hill$2,061,226
- Elizabeth Van Nostrand · University Of Pittsburgh At Pittsburgh$1,889,694
Research focus
Morbidity - Disease RatePreservationLabelMolecularMortalityPre-ClinicalGenomicsHeterogeneityMicroscopyMissionGastroesophageal AdenocarcinomaBiosensorPharmaceutical PreparationsCancer CellAscitesGastroesophageal CancerGenotypeCollectionDependenceLiquid SubstanceCellsBiopsyCell TypePublic Health
Grant awards (6)
Advanced Development of Patient Ascites Therapeutic Response Biosensors$419,133
R33 · FY2025 · CA · contact PI
Rapid ex vivo biosensor cultures to assess dependencies in gastroesophageal cancer$800,875
R01 · FY2024 · CA · contact PI
Rapid ex vivo biosensor cultures to assess dependencies in gastroesophageal cancer$563,533
R01 · FY2023 · CA · contact PI
Rapid ex vivo biosensor cultures to assess dependencies in gastroesophageal cancer$695,331
R01 · FY2022 · CA · contact PI
Rapid ex vivo biosensor cultures to assess dependencies in gastroesophageal cancer$566,213
R01 · FY2021 · CA · contact PI
Rapid ex vivo biosensor cultures to assess dependencies in gastroesophageal cancer$566,213
R01 · FY2020 · CA · contact PI